Oracle Banking Platform 2.9/2.12 SECURITY cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.1 | $0-$5k | 0.00 |
Summary
A vulnerability labeled as critical has been found in Oracle Banking Platform 2.9/2.12. Affected is an unknown function of the component Security. Such manipulation leads to an unknown weakness. This vulnerability is listed as CVE-2021-41184. The attack may be performed from remote. There is no available exploit. The affected component should be upgraded.
Details
A vulnerability was found in Oracle Banking Platform 2.9/2.12 (Banking Software) and classified as critical. Affected by this issue is an unknown part of the component SECURITY. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is confidentiality, and integrity.
The weakness was presented 07/19/2022 as Oracle Critical Patch Update Advisory - July 2022. The advisory is shared for download at oracle.com. This vulnerability is handled as CVE-2021-41184. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
The vulnerability scanner Nessus provides a plugin with the ID 211078 (Fedora 37 : drupal7 (2022-c4334d5277)), which helps to determine the existence of the flaw in a target environment.
Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.
The vulnerability is also documented in the databases at Tenable (211078) and CERT Bund (WID-SEC-2023-1015). VulDB is the best source for vulnerability data and more expert information about this specific topic.
Affected
- Oracle Health Sciences Applications
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.oracle.com
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.2VulDB Meta Temp Score: 6.1
VulDB Base Score: 6.1
VulDB Temp Score: 5.8
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CNA Base Score: 6.5
CNA Vector (GitHub, Inc.): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Nessus ID: 211078
Nessus Name: Fedora 37 : drupal7 (2022-c4334d5277)
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍
Patch: github.com
Timeline
09/15/2021 🔍07/19/2022 🔍
07/19/2022 🔍
07/20/2022 🔍
12/08/2025 🔍
Sources
Vendor: oracle.comAdvisory: Oracle Critical Patch Update Advisory - July 2022
Status: Confirmed
CVE: CVE-2021-41184 (🔍)
GCVE (CVE): GCVE-0-2021-41184
GCVE (VulDB): GCVE-100-204368
CERT Bund: WID-SEC-2023-1015 - Oracle Health Sciences Applications: Mehrere Schwachstellen
Entry
Created: 07/20/2022 08:16Updated: 12/08/2025 11:40
Changes: 07/20/2022 08:16 (39), 08/13/2022 10:53 (3), 08/13/2022 10:59 (30), 11/17/2024 13:26 (16), 04/30/2025 14:33 (3), 11/04/2025 18:34 (1), 12/08/2025 11:40 (7)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.